Bavarian Nordic A/S (BVNRY) Projected to Post Quarterly Earnings on Wednesday

Bavarian Nordic A/S (OTCMKTS:BVNRY) is anticipated to issue its quarterly earnings data on Wednesday, March 5th. Analysts expect the company to announce earnings of $0.40 per share for the quarter.

Bavarian Nordic A/S Trading Up 0.1 %

Shares of Bavarian Nordic A/S stock opened at $8.01 on Wednesday. The company’s fifty day simple moving average is $8.69 and its two-hundred day simple moving average is $10.04. The company has a market cap of $1.89 billion, a P/E ratio of 11.61 and a beta of 1.68. Bavarian Nordic A/S has a 12-month low of $6.86 and a 12-month high of $14.60.

About Bavarian Nordic A/S

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.